Formation of vasculogenic mimicry in bone metastasis of prostate cancer: Correlation with cell apoptosis and senescence regulation pathways

Pathology Research and Practice

Volumn 210, Issue 5, 2014, Pages 291-295

  Luo, Fei ^a   Yang, Kuo ^a   Liu, Ran lu ^a   Meng, Chao ^a   Dang, Rui Feng ^a   Xu, Yong ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bone metastasis; Prostate cancer; Senescence; Vasculogenic mimicry

Indexed keywords

BETA GALACTOSIDASE; CASPASE 3; CD31 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; BONE METASTASIS; CANCER CELL; CANCER INCIDENCE; CANCER PROGNOSIS; CELL AGING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NEOVASCULARIZATION (PATHOLOGY); PROSTATE CANCER; PROTEIN EXPRESSION; REGULATORY MECHANISM; SENESCENCE; STRUCTURE ANALYSIS; VASCULOGENIC MIMICRY; BONE TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROSTATE TUMOR; SECONDARY; SIGNAL TRANSDUCTION; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; APOPTOSIS; BONE NEOPLASMS; CELL AGING; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84898057227     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.01.005     Document Type: Article

References (31)

1. Nelson W.G., De Marzo A.M., Isaacs W.B. Prostate cancer. N. Engl. J. Med. 2003, 4:366-381.
2. Peyromaure E.M., Mao K., Sun Y., et al. A comparative study of prostate cancer detection and management in China and in France. Can. J. Urol. 2009, 1:4472-4477.
3. Bubendorf L., Schopfer A., Wagner U., et al. Metastatic patterns of prostate cancer: an autopsy study of 1589 patients. Hum. Pathol. 2000, 5:578-583.
4. Smith M.R., Cook R., Lee K.A., et al. Disease and host characteristics as predictors of time to first bone metastasis and death in men with progressive castration-resistant nonmetastatic prostate cancer. Cancer 2011, 10:2077-2085.
5. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 2000, 4:389-395.
6. Guzman G., Cotler S.J., Lin A.Y., et al. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma. Arch. Pathol. Lab. Med. 2007, 12:1776-1781.
7. Plate K.H., Scholz A., Dumont D.J. Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol. 2012, 6:763-775.
8. Maniotis A.J., Folberg R., Hess A., et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 1999, 3:739-752.
9. Liu C., Huang H., Donate F., et al. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res. 2002, 19:5470-5475.
10. Buijs J.T., Cleton A.M., Smit V.T., et al. Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases. Breast Cancer Res. Treat. 2004, 2:117-130.
11. Cai X.S., Jia Y.W., Mei J., et al. Tumor blood vessels formation in osteosarcoma: vasculogenesis mimicry. Chin. Med. J. (Engl.) 2004, 1:94-98.
12. Yue W.Y., Chen Z.P. Does vasculogenic mimicry exist in astrocytoma. J. Histochem. Cytochem. 2005, 8:997-1002.
13. Shirakawa K., Kobayashi H., Sobajima J., et al. Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model. Breast Cancer Res. 2003, 3:136-139.
14. Sharma N., Seftor R.E., Seftor E.A., et al. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 2002, 3:189-201.
15. Hoffmeyer M.R., Wall K.M., Dharmawardhane S.F. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Cancer Cell Int. 2005, 1:11.
16. Sun B., Zhang S., Zhang D., et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol. Rep. 2006, 4:693-698.
17. Ahmadi S.A., Moinfar M., Gohari M.K., et al. Practical application of angiogenesis and vasculogenic mimicry in prostatic adenocarcinoma. Arch. Iran. Med. 2010, 6:498-503.
18. Seftor E.A., Meltzer P.S., Kirschmann D.A., et al. Molecular determinants of human uveal melanoma invasion and metastasis. Clin. Exp. Metastasis 2002, 3:233-246.
19. Warso M.A., Maniotis A.J., Chen X., et al. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin. Cancer Res. 2001, 3:473-477.
20. Hess A.R., Seftor E.A., Gardner L.M., et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res. 2001, 8:3250-3255.
21. Liu R., Yang K., Meng C., et al. Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biol. Ther. 2012, 7:527-533.
22. Sood A.K., Fletcher M.S., Zahn C.M., et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy. Cancer Biol. Ther. 2002, 6:661-664.
23. Zhao H., Gu X.M. Study on vasculogenic mimicry in malignant esophageal stromal tumors. World J. Gastroenterol. 2008, 15:2430-2433.
24. Folberg R., Hendrix M.J., Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol. 2000, 2:361-381.
25. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 3:353-364.
26. Vartanian A.A., Burova O.S., Stepanova E.V., et al. The involvement of apoptosis in melanoma vasculogenic mimicry. Melanoma Res. 2007, 1:1-8.
27. Sun T., Sun B.C., Zhao X.L., et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology 2011, 5:1690-1706.
28. Braig M., Schmitt C.A. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 2006, 6:2881-2884.
29. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-S31.
30. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 2003, 11:2705-2715.
31. Ewald J.A., Jarrard D.F. Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer. Transl. Oncol. 2012, 4:278-287.